News
8.10.20

Interview with Reto Naef, CEO of TOPADUR PHARMA AG

 Read the full interview:

Download DocumentDokument herunterladenSwitzerland Global EnterpriseSwitzerland Global Enterprise
18.10.24
Press Release

Topadur Pharma AG Strengthens Executive Team Towards IPO

Topadur Pharma AG today announces the appointments of PD Dr. Matthias Schäfer and Prof. Dr. Jay Siegel.

Read more
6.6.24
Press Release

Topadur Pharma AG and Oshen Holdings SA sign a co-development agreement

Topadur Pharma AG and Oshen Holdings SA Partner to Develop a Treatment for Alopecia

Read more
10.9.20
Press Release

TOPADUR starts clinical development of a new wound healing drug

TOPADUR Pharma AG announces dosing of first healthy subjects in Phase 1 clinical trial of TOP-N53.

Read more

About us

NewsHistoryResearch PartnersCareers

Approach

Topadur CompoundsKey publications

Disease Areas

Lung FibrosisOncologyMedical aestheticsOphthalmologySkin FibrosisWound Healing

Investors

Investors
info@topadur.com+41 44 755 44 66
Topadur Pharma AG | Grabenstrasse 11a, 8952 Schlieren, Switzerland
ImpressumLegal Disclaimer